January 28, 2015
Galderma Japan announced on January 26 the termination of its comarketing agreement with Sato Pharmaceutical regarding the topical antifungal agent Pekiron Cream 0.5% (amorolfine HCl). Galderma will market the product independently after Sato’s inventory is exhausted. Kyorin Pharmaceutical obtained approval...read more